Leerink Partnrs Has Bearish Forecast for ARDT Q1 Earnings

Ardent Health Partners, LLC (NYSE:ARDT) – Equities researchers at Leerink Partnrs cut their Q1 2025 earnings per share estimates for shares of Ardent Health Partners in a research note issued to investors on Tuesday, April 1st. Leerink Partnrs analyst W. Mayo now expects that the company will post earnings of $0.20 per share for the quarter, down from their previous estimate of $0.33. The consensus estimate for Ardent Health Partners’ current full-year earnings is $1.23 per share. Leerink Partnrs also issued estimates for Ardent Health Partners’ Q2 2025 earnings at $0.61 EPS.

Ardent Health Partners (NYSE:ARDT) last announced its quarterly earnings data on Wednesday, February 26th. The company reported $0.81 EPS for the quarter, topping analysts’ consensus estimates of $0.50 by $0.31. The business had revenue of $1.61 billion during the quarter, compared to the consensus estimate of $1.48 billion.

A number of other analysts also recently issued reports on the company. Stephens reaffirmed an “overweight” rating and issued a $22.00 target price on shares of Ardent Health Partners in a research report on Tuesday. Morgan Stanley cut their price objective on Ardent Health Partners from $23.50 to $22.00 and set an “overweight” rating for the company in a report on Tuesday, January 21st. Truist Financial lowered their target price on shares of Ardent Health Partners from $22.00 to $21.00 and set a “buy” rating on the stock in a report on Monday, January 6th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and set a $20.00 price target on shares of Ardent Health Partners in a research report on Tuesday, December 17th. Finally, Royal Bank of Canada decreased their price objective on shares of Ardent Health Partners from $23.00 to $21.00 and set an “outperform” rating for the company in a research report on Tuesday, March 4th. Two equities research analysts have rated the stock with a hold rating, eight have given a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $21.18.

Ardent Health Partners Price Performance

Shares of ARDT stock opened at $12.22 on Friday. The firm’s fifty day moving average price is $14.25 and its two-hundred day moving average price is $16.07. Ardent Health Partners has a 1 year low of $12.13 and a 1 year high of $20.72. The company has a current ratio of 1.91, a quick ratio of 1.78 and a debt-to-equity ratio of 0.78.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of ARDT. Ventas Inc. purchased a new position in Ardent Health Partners in the 4th quarter worth $159,570,000. Wellington Management Group LLP bought a new stake in Ardent Health Partners in the 3rd quarter valued at $28,724,000. Point72 Asset Management L.P. purchased a new stake in shares of Ardent Health Partners in the third quarter worth about $27,428,000. Franklin Resources Inc. bought a new stake in Ardent Health Partners during the 3rd quarter valued at $15,839,000. Finally, Segall Bryant & Hamill LLC purchased a new position in shares of Ardent Health Partners in the 4th quarter valued at $4,478,000.

Ardent Health Partners Company Profile

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.